HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply
Transfusion · 14.11.2026
DOI: 10.1111/trf.70485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 14.11.2026. Verfasst von Emilie A Jochumsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Odense University Hospital, Odense, Denmark. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA‐antibody screening was implemented in different strategies.
Methods
Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA‐antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA‐antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD‐negative and RhD‐positive donors.
Results
The model calculated that there would be 222,239 RhD‐negative male and 74,655 nulliparous RhD‐negative female donors. If all group O RhD‐negative parous females were screened, 109,479 were calculated to not be HLA‐sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD‐negative females ≥50 years were screened, 59,138 donors would not be HLA‐sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD‐negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA‐sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD‐positive males and females were modeled.
Conclusion
HLA‐antibody screening realizes additional LTOWB donors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
- Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
- South Texas Blood & Tissue, San Antonio, Texas, USA.
- Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
- Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Emilie A Jochumsen, Jansen R Seheult, Ulrik Sprogøe, Casey Vieni, Mark H Yazer
Zitieren
APA
Jochumsen, E. A., Seheult, J. R., Ngamsuntikul, S., Taylor, A., Sprogøe, U., Vieni, C., & Yazer, M. H. (2026). HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply. Transfusion. https://doi.org/10.1111/trf.70485
Vancouver
Jochumsen EA, Seheult JR, Ngamsuntikul S, Taylor A, Sprogøe U, Vieni C, et al. HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply. Transfusion. 2026. doi:10.1111/trf.70485
BibTeX
@article{Jochumsen2026,
author = {Jochumsen, Emilie A and Seheult, Jansen R and Ngamsuntikul, Samantha and Taylor, Audra and Sprogøe, Ulrik and Vieni, Casey and Yazer, Mark H},
title = {HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70485}
}
EUVIMED